Estonia vs Netherlands: Colon and rectum cancer screening coverage in Europe
Estonia
61.5%
in 2024
Netherlands
67.1%
in 2024
Estonia rank
3rd
Netherlands rank
2nd
Colon and rectum cancer screening coverage in Europe over time
- Estonia
- Netherlands
How they compare
Netherlands currently reports 67.1% against 61.5% in Estonia, a difference of 5.6%.
That makes Netherlands's figure about 1.1 times Estonia's.
Across all 9 years both countries report, Netherlands has been ahead every year.
Estonia ranks 3rd and Netherlands ranks 2nd of 20 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Estonia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 45.5% | 72.5% | 27.0% | Netherlands |
| 2020s | 55.2% | 67.8% | 12.6% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Estonia or Netherlands?
- Netherlands, at 67.1% against 61.5% in Estonia as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between Estonia and Netherlands?
- 5.6%, with Netherlands ahead.
- How many years of comparable data are there for Estonia and Netherlands?
- 9 years are reported by both, from 2016 to 2024.
- How do Estonia and Netherlands rank globally for colon and rectum cancer screening coverage in europe?
- Estonia ranks 3rd and Netherlands ranks 2nd of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.